Navidea Biopharmaceuticals 10K 2010 Annual report | NAVB Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: acid, adjunct, ADVENTRX, Amex, Amherst, Antonio, augment, augmenting, avoid, backbone, Baker, BB, Beta, Biogen, biology, Biopharma, biotech, Boston, Brendan, camera, caption, carryforward, CBER, CC, CDER, Chair, chelating, confident, consumption, copy, Cordlife, cum, Cytomatrix, database, DD, delisted, delisting, dendritic, dental, Devicor, dextran, diethylene, disagreement, diversification, DTPA, edition, editorial, efficiency, efficient, EMA, Endowed, England, Eric, Ernst, Espicom, fellowship, felt, fluorodeoxyglucose, Ford, franchise, Frontier, furniture, guarantee, Guide, headcount, honored, Hostetler, Idec, ImClone, implant, inadvisable, JAMA, Kappa, kDa, language, largest, laude, lecturer, leverage, macromolecule, mannose, MBR, McArdle, Miami, miniature, Minretumomab, missed, mitigate, molecular, NEJM, Nortech, Northeastern, notified, NYSE, online, Oramax, pentaacetic, Phi, Primrose, push, Pykett, QTDP, radiodetection, radiotracer, ratification, receptor, recipient, recommencing, Redlen, reinitiate, Renshaw, repealed, reside, residence, resident, resume, resuming, Rodman, Roswell, Rowinsky, SBC, secondary, shorten, shutdown, Sigma, signature, slight, slower, staffing, stop, stronger, substrate, summa, surface, synthetically, Talisman, Tapestry, Tc, Technetium, thereon, Tilmanocept, Tokyo, Touche, triamine, unanticipated, underscore, uninterrupted, unqualified, unsatisfactory, USA, usable, vaccine, veterinary, Volwiler, wind, Wyeth, Zeta

Removed: accomplished, ACOSOG, acquirer, Alabama, amending, anniversary, Applicability, ARB, arm, Assuming, attestation, Auburn, bankruptcy, Birmingham, Breadsley, called, carry, category, cease, choose, COC, collateral, confirmation, content, counter, declaring, deconsolidation, deductible, default, Defense, Deputy, designing, diligent, dilute, disclosing, dissolving, East, effecting, EITF, elimination, EMEA, emitting, ensuring, essentially, excessive, existence, explaining, expressing, failing, Fay, feature, fewer, Fletcher, Florida, Frank, FSP, Gene, granting, halted, Hebrew, inactive, inconsistent, incurring, indemnify, Jerusalem, Kennedy, Kerner, KeV, Kirby, Lamar, liquidating, maker, middle, Mittai, Murry, nasdaq, negotiating, noncontrolling, noncurrent, nonfinancial, numbering, orally, OTCBB, overwhelming, parent, penny, pledged, prevailing, prohibitively, prosecuted, prospectively, proven, quotient, randomized, ratified, ratio, redemption, registering, renewed, repay, requiring, restrict, retrospectively, Reuven, revised, satisfied, satisfy, seeking, Seidman, shareholder, sought, sponsored, steep, subjecting, subordinate, suitability, supplement, surrendering, Task, therewith, UAB, unavailable, unique, validate, waiting, wealthy

Navidea Biopharmaceuticals (NAVB) 10-K2010 FY Annual report

Content analysis